| Zeit | Aktuelle Nachrichten | ||
|---|---|---|---|
| 02.02. | Quotient Therapeutics Appoints Susan Keefe as CFO | ||
| 30.01. | Lilly to Build New Pennsylvania Manufacturing Facility | ||
| 30.01. | Ardena Completes Divestment of Sweden Drug Substance Site to Nanologica | ||
| 30.01. | Merz Therapeutics Taps Dan Staner as President, Region Europe | ||
| 30.01. | Libris Innovations Taps Ramani Veranasi as CEO | ||
| 29.01. | New Veeva Application Eliminates Paper, Streamlines Clinical Trial Data Flow | ||
| 29.01. | Vetter to Build New Production Facility in Germany | ||
| 29.01. | Opentrons Formally Announces James Atwood as CEO | ||
| 29.01. | WuXi Biologics, Sinorda Biomedicine Partner to Advance SND006 | ||
| 29.01. | IQVIA to Share its DaaS+ Platform in Boehringer Ingelheim Collaboration | ||
| 29.01. | Halozyme Acquires Surf Bio for up to $400M | ||
| 29.01. | Satellos Bioscience Taps Antoinette Paone as Chief Development Officer | ||
| 28.01. | Elysium Therapeutics Raises $7.5M to Advance Opioid Overdose Reversal Tech | ||
| 28.01. | Cellares Raises $257M to Industrialize Global Cell Therapy Manufacturing | ||
| 28.01. | Fujirebio Unveils CSF Assay to Assist Alzheimer's Research | ||
| 28.01. | Veranova Taps Former Alcami Exec as Chief Quality Officer | ||
| 28.01. | Halo Pharma Becomes Stand-Alone CDMO Business | ||
| 28.01. | Single Use Support Appoints Davy De Wilde as Chief Commercial Officer | ||
| 27.01. | Integrated Biosciences Names Daniel J. Anderson CSO | ||
| 27.01. | ICON Opens New Cancer Institute in Illinois | ||
| 27.01. | BioMed X Launches Research in Barbados for AI-Enabled Early Diabetic Kidney Disease Therapy | ||
| 27.01. | Boehringer Ingelheim, Simcere Partner on Antibody Treatment for IBD | ||
| 27.01. | Siegfried Acquires Small Molecule Drug Substance Capacity in the U.S. | ||
| 27.01. | iOrganBio Taps Karol Jarzabek as Chief Operating Officer | ||
| 27.01. | Multiply Labs, AstraZeneca Partner to Automate Cell Therapy Mfg. with Robotics |